Abstract Objective: To compare colonization and catheter-related bloodstream infection (CR-BSI) rates among three insertion sites (subclavian, internal jugular, femoral) used for central venous catheter (CVC) placement. Design: Twenty-fourmonth prospective study, with relative effects analyzed by Cox proportional hazards regression. Setting: Eightbed intensive care unit. Patients: Four hundred and ten critically ill patients requiring CVC placement. Measurements and results: All shortterm multi-lumen CVCs, including antimicrobial-coated devices, were studied with management standardized. Six hundred and five CVCs (4,040 catheter days) were analyzed. Colonization and CR-BSI incidence were, respectively, 15.1 (95% CI 13.5-21.0) and 1.8 (95% CI 1.2-4.2) per 1,000 catheter-days. Colonization was higher at the internal jugular (HR 3.64; 95% CI 1.32-10.00; p = 0.01) and femoral (HR 5.15; 95% CI 1.82-14.51; p = 0.004) sites than at the subclavian site. The femoral site carried a greater risk of being colonized by non-S. epidermidis species than the subclavian and internal jugular sites combined (HR 4.15; 95% CI 1.79-9.61; p = 0.001). CVCs inserted in the Department of Emergency Medicine were more colonized than those inserted in the ICU or operating room (HR 2.66; 95% CI 1.27-5.56; p = 0.01), and CVCs were less colonized in females than in males (HR 0.49; p = 0.02). No difference in CR-BSI rates was noted between the three sites. Conclusions: Colonization was lowest at the subclavian site. Regional differences exist with respect to type of pathogen isolated. Colonization was influenced by insertion location and gender. The incidence of CR-BSI was not different.
Introduction
Complications of central venous catheters (CVCs) can be classified as mechanical and infective [1, 2] . Although increasing awareness of CVC-related infection has resulted in effective guidelines [3] , CVC s remain an important cause of nosocomial sepsis in the critically ill.
CVCs can be placed via the internal jugular, subclavian and femoral veins. Several studies have compared rates of infection among the three sites sequentially [2, 4, 5] , and concurrently [6] [7] [8] [9] [10] . The Hospital Infection Control Advisory Committee (HICPAC) [11] has consistently recommended the subclavian site for prevention of infection (evidence level 1A). A number of publications, however, have suggested similar rates of mechanical and infective complication between femoral and upper body sites [12] [13] [14] [15] . Some of these studies were in particular subgroups, such as children and burns patients [15, 16] , and in others the conclusions were controversial [14, 17] .
In our intensive care unit (ICU) all three vascular access sites were routinely used and accurate data on CVC infection rates were prospectively collected. Due to the conflicting reports in the literature we sought to compare the infective outcomes and risk factors among CVCs placed at all three sites.
Materials and methods
This prospective observational study was carried out over 24 months in an eight-bed ICU of a 350-bed regional Australian teaching hospital. The ICU treated all forms of acute illnesses excluding cardiac surgical and neurosurgical patients. Admission and treatment rights in the ICU are limited to intensivists, and the unit is staffed by critical care registered nurses.
All short-term non-tunneled CVCs (including peripherally inserted central lines); both regular and antimicrobial coated (AM) that presented to, or were inserted in, the ICU were included in the study. Pulmonary artery catheters, their introducer sheaths, and long-term access devices (e.g. Hickman's catheters) were not studied. The study was approved by the institution as a quality improvement project.
Data collection
For study entry the CVC had to have been inserted in the department of emergency medicine (DEM), the operating room (OR) or the ICU. CVCs inserted in other hospitals were not included. CVCs were excluded if removal and microbiological sampling violated the study protocol. On admission to the ICU, CVCs were identified with a unique identifier label which was attached to an external lumen. The following data were collected for each CVC: insertion details (time, place, and operator level of experience), CVC type (regular or AM, lumen size), anatomical insertion site, and CVC removal details (date, time, reason, and location). Patients were followed after ICU discharge when this occurred prior to CVC removal. Other data collected included 24-h APACHE and SAPS-II scores, APACHE-II diagnostic codes, age, and sex. Data on patient co-morbidity or thrombotic events was not recorded. Microbiological details, including all catheter tip culture, blood culture, and microorganisms isolated were collected concurrently.
CVC management
Insertion of CVCs was performed by appropriately trained operators (consultants, registrars, or residents). All regular (non-AM) CVCs used were multi-lumen 20-cm polyurethane devices (Arrow ® International, Reading, PA, USA) inserted using a Seldinger approach under maximum sterile barrier precautions (sterile gloves, gown, large drapes, mask, and cap). Chlorhexidine 0.5% in 70% ethanol was used as skin antisepsis. AM catheters were ARROWguard Blue ® (Arrow ® International). These were also 20-cm multi-lumen devices inserted under identical conditions. No antibiotic-coated CVCs were used. AM CVCs were used at the discretion of the medical team and placed if the clinician expected the CVC in-situ duration to exceed 7 days or if the patient was clinically judged to be at high risk of developing CR-BSI. Insertion was not, however, subject to protocol. All patients had upper body CVC tip placement confirmed by plain chest X-ray. For both types of CVC, choice of insertion site was based on patient variables (e.g., risk of pneumothorax) and level of operator experience.
The CVC insertion site was inspected daily as part of the multidisciplinary ICU ward round. All line manipulations were performed by ICU nursing staff and managed according to current guidelines [11] . CVCs were not used routinely for blood sampling, and guide-wire exchange was not performed. The CVC was not changed on a scheduled basis but removed for clinical suspicion (temperature > 38°C or < 36°C, leukocytosis or leukopenia, hemodynamic instability, no other obvious site) of sepsis (with culture of the catheter tip and peripheral blood), mechanical failure, or when no longer required. All patients, if possible, had their CVC removed prior to discharge to the general wards and peripheral IV access inserted if intravenous therapy was still deemed necessary [18] .
Microbiological sampling
The distal 3-to 5-cm of the CVC tip was removed by the bedside ICU nurse, using a sterile dressing pack which included sterile forceps and scissors, taking care not to con-taminate the tip on removal. The tip was then immediately transferred to a sterile container and transported to the microbiology department [19] .
Microbiological definitions
The following definitions of CVC infection were applied [11] .
• a Of the 618 CVCs, the site was not recorded in 13 cases; AM, Anti-microbial CVC. Colonization (>15 CFU): n = number observed and as % of total CVCs colonized at time of CVC removal with associated rate, calculated by Poisson regression adjusted for age, gender, APACHE and SAPS-II scores. CR-BSI: n = number observed and as % of total CVCs inserted at each site. Figure 1 demonstrates the cumulative incidence of CVC colonization at the time of catheter removal. Further analysis of colonization and CR-BSI incidence was performed only on the 589 CVCs that were sited at the internal jugular (regular 204, AM 75), subclavian (regular 59, AM 43), and femoral (regular 150, AM 58) sites. Mean duration of catheterization at internal jugular, subclavian, and femoral sites for regular and AM catheters respectively was 5.5, 7.4, and 5.4 days and 8.5, 9.2, and 5.7 days, with a significant difference in dwell time noted only for the internal jugular site (p = 0.001). There were nine episodes of CR-BSI, which are listed by CVC type in Table 1 . CR-BSI rates per 1,000 catheter days at internal jugular and femoral sites were not significantly different from the subclavian site (1.26; HR 1.0). The rate at the internal jugular site was 2. Table 2 shows colonization rates and multivariate estimates of the simultaneous effects of differing risk factors for CVC colonization at all sites combined, and Table 3 at individual sites, after stepwise removal of insignificant (p > 0.2) variables. The final model found that the only factors significantly associated with colonization were non-subclavian site, DEM insertion location, male gender, and use of regular CVCs.
Colonization at the internal jugular (HR 3.64; 95% CI 1.32-10.00; p = 0.01) and femoral (HR 5.15; 95% CI 1.82-14.51; p = 0.004) sites was significantly greater than at the subclavian (Fig. 2) . Colonization at the femoral was not different from that at the internal jugular (HR 1.31; 95% CI 0.54-3.21; p = 0.34). CVCs inserted in the DEM were significantly more colonized than those inserted in the ICU or OR (p = 0.01). CVCs were significantly less colonized in females than in males (p = 0.02); this effect was most marked at the internal jugular site (p = 0.003). There was a significant reduction in colonization when AM CVCs were used compared with regular CVCs (p = 0.02). At individual sites this effect was greatest at the internal jugular (p = 0.03) but not significant at the femoral (p = 0.50). Rates of colonization were similar if CVCs were inserted by registrars and residents (HR 1.22, 95% CI 0.31-3.59 p = 0.723) compared with specialists. Table 4 displays colonization and admitting diagnosis. Colonization was lower in those patients with a primary diagnosis of sepsis or other major infection (p = 0.05).
A total of 81 microorganisms were responsible for the 68 CVC colonizations (Table 5) , of which 62 (76.5%) were Gram-positive bacteria, 14 (17.3%) were Gram-negative bacteria, and 5 (6.2%) were yeasts. Colonizing species were as follows: 50 (61.7%) Staphylococcus epidermidis; 12 (14.8%) Enterococcus faecalis; 9 (11.1%) S. aureus; Subclavian  3  2  1  0  0  0  102  Internal  35  1  3  3  0  0  279  jugular  Femoral  11  6  8  2  2  3  208  Cubital  1  0  0  0  0  0  16  Total  50  9  12  5  2  3 605 (n = 81)
The likelihood of heavy colonization with non-S. epidermidis organisms was greater at the femoral site than at the subclavian and internal jugular sites combined (HR 4.15; 95% CI 1.79-9.61; p = 0.001). At the internal jugular 83% of isolates were S. epidermidis, compared with 34% at the femoral site. The likelihood of heavy colonization with non-S. epidermidis organisms was significantly greater at the femoral site than at the subclavian and internal jugular combined (HR 4.15; 95% CI 1.79-9.61; p = 0.001); the subclavian and internal jugular sites were similar in the respect (HR 2.01; 95% CI 0.23-17.6; p = 0.52).
Discussion
We have shown that in an environment of consistent CVC care, catheter tip colonization was significantly lower when the device was inserted via the subclavian route. Rates of colonization for internal jugular and femoral sites were not different. Colonization was also significantly lower when the device was inserted in the ICU or the OR, and in female patients. The spectrum of colonizing species differed at the femoral insertion site. For all CVCs no significant difference was detected in CR-BSI rate among sites.
The HICPAC guidelines [11] for the prevention of CVC infection recommend that the subclavian site be used preferentially for CVC catheterization to reduce the incidence of catheter-related infection. This is based on four studies, including Merrer's randomized controlled trial comparing femoral and subclavian sites [2] and Goetz's prospective observational study [7] . The former study found that catheterization at the femoral site was associated with a 5 times greater incidence of catheter-related infection than the subclavian site. In particular, when the endpoints of colonization plus CR-BSI were combined this difference was highly significant. Goetz [7] also found catheter contamination to be associated with femoral location (HR 4.2; p = 0.0001) and a trend towards greater clinical infection at the same site (HR 4.7; p = 0.08). Colonization rates in this study were comparable with our own at 28.8/1,000 and 5.8/1,000 CVC days for internal jugular and subclavian sites respectively, but appeared lower than ours at the femoral site (12.6/1,000 CVC days). Other studies have produced conflicting results. Although Collignon [6] found a significantly higher colonization rate with catheters inserted at the femoral site than at the subclavian site, Richet [8] found the internal jugular, not the femoral site, to be independently associated with positive tip culture. Deshpande [14] found that there was no significant difference in the rate of infection including BSI or colonization at three concurrently studied sites. These data led the authors to conclude that all three sites had similar risks of infection, providing site selection was appropriate and the device was inserted by trained personnel with appropriate infection control measures. Another study which examined infection rates at all three sites concurrently [10] found that catheter-related local infection (signs of local infection plus colonization) incidence density was statistically significantly higher for femoral than for internal jugular (15.83 vs. 7.65; p < 0.001) and subclavian (15.83 vs. 1.57; p < 0.001) access routes, and higher for internal jugular than subclavian access (7.65 vs. 1.57; p < 0.001). CR-BSI incidence density was also statistically higher for femoral than for internal jugular (8.34 vs. 2.99; p = 0.002) and subclavian (8.34 vs. 0.97; p < 0.001) accesses.
A common theme through all of these studies is that the subclavian site is associated with the lowest rates of colonization and CR-BSI. Our results support this, in that at this site the colonization rate was significantly lower than at either the internal jugular or the femoral site. Although in our investigation rates of CR-BSI were equivalent, the study was not sufficiently powered to detect a difference. Colonization would, however, appear to be a valid surrogate and correlates powerfully with the subsequent development of CR-BSI [20] .
In clinical practice, selection of anatomical site is made after consideration of patient variables, operator experience, and institutional policy. In those at risk of mechanical complications with upper body sites, the femoral may be the safest access route. The perception that subclavian access is more prone than internal jugu-lar insertion to mechanical complication may not be warranted, with one study suggesting no difference in the incidence of hemo-pneumothorax between the two sites [21] . These results must be interpreted with caution because they represent a meta-analysis of non-randomized studies and exclude certain high-risk sub-groups such as patients with acute respiratory distress syndrome.
Other factors influenced the colonization rates at differing sites. We observed a clear colonization benefit in favor of females at the internal jugular but not subclavian or femoral sites. The higher rate in males may in part be explained by the presence of facial hair, which may extend to around the insertion site, increasing the risk of contamination.
Although numbers were small, devices inserted in the DEM, had higher rates of colonization than those inserted in either ICU or OR. This may be explained by the often emergent insertion in this environment where sterility may be suboptimal. CVCs inserted in these conditions should be replaced as soon as practicable.
It is recognized that anatomical insertion site may influence the type of bacteria isolated [22, 23] . Lorente [23] recently demonstrated that the femoral site is an independent risk factor for BSI due to yeasts and Gram-negative organisms. Our results also suggest that the femoral site carries a significantly greater risk of infection than the internal jugular or subclavian sites for non-S. epidermis organisms. This may have implications for treatment of suspected CR-BSI arising from the femoral site, where organisms of significantly greater virulence may be responsible.
Our study has a number of limitations which need to be considered when interpreting the results. Despite the fact that insertion, use, and maintenance of the CVCs studied were uniform, this was not a randomized comparison. It is possible that femoral selection may be biased toward emergent insertions which will lead to higher colonization. Additionally, despite the fact that we controlled for severity of illness it is possible that bias occurred in patient selection, with certain subgroups of patients more prone to femoral (and avoidance of subclavian) insertion, e.g., severe respiratory failure.
Although catheter tip colonization, a valid surrogate of BSI [20] , remains unequivocally different between the three sites, due to the very low rate of CR-BSI, our study was underpowered to detect differences in this outcome measure. With quality improvement initiatives the use of CR-BSI as an outcome may become problematic as the overall incidence of bloodstream infection continues to reduce. Colonization may therefore become a more valid and practically achievable end point in future studies.
Overall, although AM CVCs have been associated with up to 50% reductions in both colonization rates and incidence of CR-BSI in multiple studies [24] , controversy exists with regard to their role [25] [26] [27] . Our results are consistent with those previously reported, with significant reductions in colonization compared with regular CVCs. Our study was, however, not designed to demonstrate an outcome benefit for the use of AM CVCs, and analysis was limited by small numbers and potentially confounded by the impact of the external antiseptic coating on inoculum growth using the roll-plate technique.
Finally, several factors shown to impact on rates of infection were not specifically included in our analyses; in particular, administration of parenteral nutrition solutions and nurse-patient ratios. These variables would be useful additions in future studies.
In conclusion, our study demonstrated that in our institution, subclavian insertion is associated with the lowest rate of catheter tip colonization among the three commonly used insertion sites for routine CVC placement. Rates of colonization were similar between internal jugular and femoral placement, with a higher incidence of non-S. epidermidis infection at the femoral site. Insertion in the DEM and insertion in male patients were associated with higher rates of colonization.
